Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Bear Of The Day: Illumina
Article By:
Kevin Cook
Monday, October 9, 2023 10:45 AM EDT
Illumina, the maker of million-dollar genome sequencing machines that revolutionized the fields of genetics and biotechnology, has fallen hard in the past year.
In this article: ILMN
Elliott Wave Technical Analysis: Illumina Inc.
Article By:
Peter Mathers
Tuesday, August 15, 2023 8:27 AM EDT
Looking for shorts with invalidation at $195.
In this article: ILMN
Icahn Reacts Audaciously To Illumina’s Audacity
Article By:
Lipper Alpha Insight
Wednesday, March 15, 2023 7:13 AM EDT
Carl Icahn has correctly diagnosed what ails Illumina, but he is prescribing an overly aggressive treatment. The pushy billionaire wants three board seats at the biotechnology company, after it overpaid for Grail and took on too much regulatory risk.
In this article: ILMN
Illumina Gains But Lags Market: What You Should Know
Article By:
Zacks Investment Research
Monday, October 24, 2022 8:18 PM EDT
In the latest trading session, Illumina (ILMN) closed at $220.57, marking a +0.25% move from the previous day. This move lagged the S&P 500's daily gain of 1.19%. Meanwhile, the Dow gained 1.34%, and the Nasdaq, a tech-heavy index, lost 0.18%.
In this article: ILMN
Illumina: A Growth Leader In The Genomic Revolution
You make some good points. I've reconsidered buying $ILMN.